248 related articles for article (PubMed ID: 10373425)
1. Purification and characterization of a complex containing matriptase and a Kunitz-type serine protease inhibitor from human milk.
Lin CY; Anders J; Johnson M; Dickson RB
J Biol Chem; 1999 Jun; 274(26):18237-42. PubMed ID: 10373425
[TBL] [Abstract][Full Text] [Related]
2. Regulation of the activity of matriptase on epithelial cell surfaces by a blood-derived factor.
Benaud C; Dickson RB; Lin CY
Eur J Biochem; 2001 Mar; 268(5):1439-47. PubMed ID: 11231297
[TBL] [Abstract][Full Text] [Related]
3. Matriptase Complexes and Prostasin Complexes with HAI-1 and HAI-2 in Human Milk: Significant Proteolysis in Lactation.
Lai CH; Lai YJ; Chou FP; Chang HH; Tseng CC; Johnson MD; Wang JK; Lin CY
PLoS One; 2016; 11(4):e0152904. PubMed ID: 27043831
[TBL] [Abstract][Full Text] [Related]
4. Matriptase and HAI-1 are expressed by normal and malignant epithelial cells in vitro and in vivo.
Oberst M; Anders J; Xie B; Singh B; Ossandon M; Johnson M; Dickson RB; Lin CY
Am J Pathol; 2001 Apr; 158(4):1301-11. PubMed ID: 11290548
[TBL] [Abstract][Full Text] [Related]
5. Tissue expression, protease specificity, and Kunitz domain functions of hepatocyte growth factor activator inhibitor-1B (HAI-1B), a new splice variant of HAI-1.
Kirchhofer D; Peek M; Li W; Stamos J; Eigenbrot C; Kadkhodayan S; Elliott JM; Corpuz RT; Lazarus RA; Moran P
J Biol Chem; 2003 Sep; 278(38):36341-9. PubMed ID: 12815039
[TBL] [Abstract][Full Text] [Related]
6. Roles of functional and structural domains of hepatocyte growth factor activator inhibitor type 1 in the inhibition of matriptase.
Kojima K; Tsuzuki S; Fushiki T; Inouye K
J Biol Chem; 2008 Feb; 283(5):2478-87. PubMed ID: 18048349
[TBL] [Abstract][Full Text] [Related]
7. Deregulated activation of matriptase in breast cancer cells.
Benaud CM; Oberst M; Dickson RB; Lin CY
Clin Exp Metastasis; 2002; 19(7):639-49. PubMed ID: 12498394
[TBL] [Abstract][Full Text] [Related]
8. Purification from human milk of matriptase complexes with secreted serpins: mechanism for inhibition of matriptase other than HAI-1.
Tseng IC; Chou FP; Su SF; Oberst M; Madayiputhiya N; Lee MS; Wang JK; Sloane DE; Johnson M; Lin CY
Am J Physiol Cell Physiol; 2008 Aug; 295(2):C423-31. PubMed ID: 18550704
[TBL] [Abstract][Full Text] [Related]
9. The activation of matriptase requires its noncatalytic domains, serine protease domain, and its cognate inhibitor.
Oberst MD; Williams CA; Dickson RB; Johnson MD; Lin CY
J Biol Chem; 2003 Jul; 278(29):26773-9. PubMed ID: 12738778
[TBL] [Abstract][Full Text] [Related]
10. Potent inhibition and global co-localization implicate the transmembrane Kunitz-type serine protease inhibitor hepatocyte growth factor activator inhibitor-2 in the regulation of epithelial matriptase activity.
Szabo R; Hobson JP; List K; Molinolo A; Lin CY; Bugge TH
J Biol Chem; 2008 Oct; 283(43):29495-504. PubMed ID: 18713750
[TBL] [Abstract][Full Text] [Related]
11. Crystal structures of matriptase in complex with its inhibitor hepatocyte growth factor activator inhibitor-1.
Zhao B; Yuan C; Li R; Qu D; Huang M; Ngo JC
J Biol Chem; 2013 Apr; 288(16):11155-64. PubMed ID: 23443661
[TBL] [Abstract][Full Text] [Related]
12. The Kunitz Domain I of Hepatocyte Growth Factor Activator Inhibitor-2 Inhibits Matriptase Activity and Invasive Ability of Human Prostate Cancer Cells.
Wu SR; Teng CH; Tu YT; Ko CJ; Cheng TS; Lan SW; Lin HY; Lin HH; Tu HF; Hsiao PW; Huang HP; Chen CH; Lee MS
Sci Rep; 2017 Nov; 7(1):15101. PubMed ID: 29118397
[TBL] [Abstract][Full Text] [Related]
13. Differential subcellular localization renders HAI-2 a matriptase inhibitor in breast cancer cells but not in mammary epithelial cells.
Chang HH; Xu Y; Lai H; Yang X; Tseng CC; Lai YJ; Pan Y; Zhou E; Johnson MD; Wang JK; Lin CY
PLoS One; 2015; 10(3):e0120489. PubMed ID: 25786220
[TBL] [Abstract][Full Text] [Related]
14. Matriptase-2, a membrane-bound mosaic serine proteinase predominantly expressed in human liver and showing degrading activity against extracellular matrix proteins.
Velasco G; Cal S; Quesada V; Sánchez LM; López-Otín C
J Biol Chem; 2002 Oct; 277(40):37637-46. PubMed ID: 12149247
[TBL] [Abstract][Full Text] [Related]
15. Conformational lability in serine protease active sites: structures of hepatocyte growth factor activator (HGFA) alone and with the inhibitory domain from HGFA inhibitor-1B.
Shia S; Stamos J; Kirchhofer D; Fan B; Wu J; Corpuz RT; Santell L; Lazarus RA; Eigenbrot C
J Mol Biol; 2005 Mar; 346(5):1335-49. PubMed ID: 15713485
[TBL] [Abstract][Full Text] [Related]
16. Engineering a potent inhibitor of matriptase from the natural hepatocyte growth factor activator inhibitor type-1 (HAI-1) protein.
Mitchell AC; Kannan D; Hunter SA; Parra Sperberg RA; Chang CH; Cochran JR
J Biol Chem; 2018 Apr; 293(14):4969-4980. PubMed ID: 29386351
[TBL] [Abstract][Full Text] [Related]
17. Functional characterization of Kunitz domains in hepatocyte growth factor activator inhibitor type 1.
Denda K; Shimomura T; Kawaguchi T; Miyazawa K; Kitamura N
J Biol Chem; 2002 Apr; 277(16):14053-9. PubMed ID: 11805118
[TBL] [Abstract][Full Text] [Related]
18. Molecular cloning of cDNA for matriptase, a matrix-degrading serine protease with trypsin-like activity.
Lin CY; Anders J; Johnson M; Sang QA; Dickson RB
J Biol Chem; 1999 Jun; 274(26):18231-6. PubMed ID: 10373424
[TBL] [Abstract][Full Text] [Related]
19. High-affinity cyclic peptide matriptase inhibitors.
Quimbar P; Malik U; Sommerhoff CP; Kaas Q; Chan LY; Huang YH; Grundhuber M; Dunse K; Craik DJ; Anderson MA; Daly NL
J Biol Chem; 2013 May; 288(19):13885-96. PubMed ID: 23548907
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of an active zymogen protease: the zymogen form of matriptase is regulated by HAI-1 and HAI-2.
Skovbjerg S; Holt-Danborg L; Nonboe AW; Hong Z; Frost ÁK; Schar CR; Thomas CC; Vitved L; Jensen JK; Vogel LK
Biochem J; 2020 May; 477(9):1779-1794. PubMed ID: 32338287
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
